Behavioral analysis during the forced swimming test using a joystick device

Journal of Neuroscience Methods

Volumn 143, Issue 2, 2005, Pages 117-121

  Gersner, Roman ^a   Dar, Dalit E ^a   Shabat Simon, Maytal ^a   Zangen, Abraham ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Animal model; Antidepressant; Depression; Gaussian distribution; Swim test

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; PROMETHAZINE;

ANALYTICAL EQUIPMENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SCIENCE; BREEDING; COMPUTER; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; ERROR; FORCED SWIMMING TEST; LIMB MOVEMENT; MALE; MOTIVATION; NONHUMAN; NORMAL DISTRIBUTION; PRIORITY JOURNAL; RAT; SCORING SYSTEM; VALIDATION PROCESS;

EID: 16244417477     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2004.09.017     Document Type: Article

References (19)

1. F. Borsini, and A. Meli Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 94 1988 147 160
2. F. Borsini, G. Volterra, A. Lecci, S. Evangelista, A. Mancinelli, and C. Cutrufo Potential antidepressant activity and enhancement of serotonin uptake of a new dibenzothiadiazepine derivative Arzneimittelforschung 41 1991 573 580
3. A. Delini-Stula, E. Radeke, and H. van Riezen Enhanced functional responsiveness of the dopaminergic system - the mechanism of anti-immobility effects of antidepressants in the behavioural despair test in the rat Neuropharmacology 27 1988 943 947
4. J.M. De Pablo, A. Parra, S. Segovia, and A. Guillamon Learned immobility explains the behavior of rats in the forced swimming test Physiol Behav 46 1989 229 237
5. M.J. Detke, and I. Lucki Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth Behav Brain Res 73 1996 43 46
6. M. Fava, and K.S. Kendler Major depressive disorder Neuron 28 2000 335 341
7. D.G. Healy, A. Harkin, J.F. Cryan, J.P. Kelly, and B.E. Leonard Metyrapone displays antidepressant-like properties in preclinical paradigms Psychopharmacology (Berl) 145 1999 303 308
8. G. Hedou, C. Pryce, L. Di Iorio, C.A. Heidbreder, and J. Feldon An automated analysis of rat behavior in the forced swim test Pharmacol Biochem Behav 70 2001 65 76
9. A.L. Hudson, R.J. Tyacke, M.D. Lalies, N. Davies, D.P. Finn, and O. Marti Novel ligands for the investigation of imidazoline receptors and their binding proteins Ann NY Acad Sci 1009 2003 302 308
10. I. Lucki The forced swimming test as a model for core and component behavioral effects of antidepressant drugs Behav Pharmacol 8 1997 523 532
11. S. Nomura, J. Shimizu, M. Kinjo, H. Kametani, and T. Nakazawa A new behavioral test for antidepressant drugs Eur J Pharmacol 83 1982 171 175
12. E. Palaska, M. Aytemir, I.T. Uzbay, and D. Erol Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines Eur J Med Chem 36 2001 539 543
13. E. Panconi, J. Roux, M. Altenbaumer, S. Hampe, and R.D. Porsolt MK-801 and enantiomers: potential antidepressants or false positives in classical screening models? Pharmacol Biochem Behav 46 1993 15 20
14. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioural despair in rats: a new model sensitive to antidepressant treatments Eur J Pharmacol 47 1978 379 391
15. R.D. Porsolt, M. Le Pichon, and M. Jalfre Depression: a new animal model sensitive to antidepressant treatments Nature 266 1977 730 732
16. A.R. Sanders, S.D. Detera-Wadleigh, and E.S. Gershon Molecular genetics of mood disorders Bunney Neurobiology of mental illness 1999 Oxford University Press New York 299 316
17. S.S. Shapiro, and M.B. Wilk An analysis of variance test for normality (complete samples) Biometrika 52 1965 591 611
18. T. Shimazoe, S. Shibata, and S. Ueki A new forced swimming test for the evaluation of antidepressants in rats by recording vibration of a water tank J Pharmacobiodyn 10 1987 639 643
19. E.H. Wong, M.S. Sonders, S.G. Amara, P.M. Tinholt, M.F. Piercey, and W.P. Hoffmann Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor Biol Psychiatr 47 2000 818 829